Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

COVID-10 GPH

COVID-19 GPH|Home|PHGKB

Rare Disease

Last data update: Dec 02, 2021 . (Total: 28409 Documents since 2020)
   dataset      

Filtered By:

Previous    

Records 1-21 (of 21 Records)

Query Trace: Macrophage Activation Syndrome[original query]
Evaluation of the relationship between pentraxin 3 (PTX3) rs2305619 (281A/G) and rs1840680 (1449A/G) polymorphisms and the clinical course of COVID-19.
Kerget Ferhan, et al. Journal of medical virology 2021 0 0.
type type
Frequency of interleukin-6 rs1800795 (-174G/C) and rs1800797 (-597G/A) polymorphisms in COVID-19 patients in Turkey who develop macrophage activation syndrome.
Kerget Ferhan, et al. Japanese journal of infectious diseases 2021 0 0.
type type
COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue.
Yongzhi Xi, et al. Emerging microbes & infections 2021 0 0. (1) 266-276
Status of mannose-binding lectin (MBL) and complement system in COVID-19 patients and therapeutic applications of antiviral plant MBLs.
Gupta Anita, et al. Molecular and cellular biochemistry 2021 3 0.
type type
Immune cartography of macrophage activation syndrome in the COVID-19 era.
McGonagle Dennis, et al. Nature reviews. Rheumatology 2021 2 0.
type type type
Response to: 'Correspondence on 'Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences' by Ruscitti et al' by Chen et al.
Ruscitti Piero, et al. Annals of the rheumatic diseases 2020 0 0.
Inflammasomes and Childhood Autoimmune Diseases: A Review of Current Knowledge.
Yang Chin-An, et al. Clinical reviews in allergy & immunology 2020 11 0.
type type type
COVID-19: A Great Mime or a Trigger Event of Autoimmune Manifestations?
Fatone Maria Celeste, et al. Current rheumatology reviews 2020 10 0.
type type
Preliminary predictive criteria for COVID-19 cytokine storm.
Caricchio Roberto, et al. Annals of the rheumatic diseases 2020 9 0.
type type
Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease.
Zhang Rui Long, et al. Current opinion in pharmacology 2020 9 0. 72-81
type
Correspondence on 'Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences' by Ruscitti et al.
Chen Acer I-Hung, et al. Annals of the rheumatic diseases 2020 9 0.
Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications.
Banu Nehla, et al. Life sciences 2020 9 0. 117905
type type
Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences.
Ruscitti Piero, et al. Annals of the rheumatic diseases 2020 7 0.
type
The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease.
McGonagle Dennis, et al. Autoimmunity reviews 2020 6 0. (6) 102537
type type
Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin.
Alunno Alessia, et al. RMD open 2020 0 0. (1)
type
COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?
Colafrancesco Serena, et al. Autoimmunity reviews 2020 7 0. (7) 102573
type type
Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure.
Abplanalp Wesley Tyler, et al. JAMA cardiology 2020 7 0.
type type type
Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.
Soy Mehmet, et al. Rheumatology international 2020 6 0.
type
Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms.
Criado Paulo Ricardo, et al. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2020 6 0.
type type
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment.
Soy Mehmet, et al. Clinical rheumatology 2020 5 0.
type type
The CoV-2 outbreak: how hematologists could help to fight Covid-19.
Galimberti Sara, et al. Pharmacological research 2020 5 0. 104866
type type
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
TOP